Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Depressive Symptoms in Adolescents With MDD at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Psychoactive-Controlled Study.

Subjects

Subjects :

*SUICIDE risk factors
*MENTAL depression
*TEENAGERS
*SAFETY

Details

Language :

English

ISSN :

08908567

Volume :

62

Issue :

10

Database :

Academic Search Index

Journal :

Journal of the American Academy of Child & Adolescent Psychiatry

Publication Type :

Academic Journal

Accession number :

172889863

Full Text :

https://doi.org/10.1016/j.jaac.2023.09.513